HITIQ Ltd (hiq) Logo

HITIQ Ltd (HIQ)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

HIQ Chart

Snapshot

HIQ's Principal Activity is the building and commercialising a technology platform to assist in the surveillance, detection, assessment and diagnosis of sports related concussion injury.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -25.11%

Size

Market Capitalisation
ASX Rank 1,734 of 2,316
Sector Rank 165 of 198

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies UCM / 1AD / RGS
EPS $0.00
DPS $0.00
NTA per share $0.00

Broker Consensus

HIQ is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

HitIQ Limited (HIQ) operates in the health technology market providing data driven solutions for brain injury prevention, condition management and improvements in brain function and subsequently physical performance. HitIQ's core product is the Nexus A9 Sensor Device.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office South Melbourne VIC 3205
Website www.hitiq.com
Registry Automic Group
Auditor Bentleys Audit & Corporate (WA) Pty Ltd
Date Listed 16 Jun 2021

Upcoming Calendar (Forecasted)

Date Event
29/08/2022 Report (Prelim)
28/09/2022 Report (Annual)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Aidan Clarke Non-Executive Director Apr 2021 Director Bio icon

Mr Aidan Clarke

Non-Executive Director

Mr Clarke is an experienced entrepreneur with close to 15 years' experience within the sporting industry. Having co-founded sporting brand 2XU, Mr Clarke was an Executive Director responsible for the Sales & Marketing functions of the company. Mr Clarke led 2XU commercialization efforts into numerous sport relationships, such as a long serving AIS R&D agreement and signing multiple partnerships across teams and institutions throughout the world. 2XU was partially acquired by the LVMH capital arm L-Capital in 2014, with Mr Clarke fully exiting his shareholding in 2018.

Mr Otto Leslie Steven Buttula Non-Executive Chairman,Non-Executive Director Jan 2021 Director Bio icon

Mr Otto Leslie Steven Buttula

Non-Executive Chairman,Non-Executive Director

Mr Buttula has experience in investment research, funds management and information/biotechnology, holding directorships in a number of public companies. Mr Buttula's executive experience includes as a co-founder, CEO and Managing Director of IWL Ltd, an online financial services company that listed on the ASX in 1999. It was taken over in 2007 by Commonwealth Bank of Australia (ASX: CBA). Mr Buttula also founded and was Managing Director of Investors Mutual, prior to which he was a co-founder and director of Lonsdale Securities Ltd. Following his completion of executive duties, Mr Buttula was Non-Executive Chairman of platform and stockbroking provider Investorfirst Ltd and led the acquisition of HUB24 Ltd (ASX: HUB). More recently, he served on the Board as a non-executive director and Head of Audit & Risk at Imugene Ltd (ASX: IMU) between 2014 and 2016. Currently, Mr Buttula is also Non-Executive Chairman of Rhythm Biosciences Ltd (ASX: RHY).

Mr Glenn Smith Non-Executive Director Jan 2020 Director Bio icon

Mr Glenn Smith

Non-Executive Director

Mr Smith is an experienced CEO, entrepreneur, investor and director. He has over 20 years' experience in building and growing customer-centric businesses at all stages of the growth cycle (listed and private) from existence (start-ups), to mature global enterprises in the areas of AR/VR, Healthtech, Telco, Edtech Fintech, Blockchain, Digital Identity, Personal data, Agtech & HR Marketplaces. Glenn is currently Managing Director of TALi Digital Limited (ASX:TD1) a company involved in digital diagnostics and therapeutics for neurological conditions. Mr Smith spent 6 years at Optus, where he lead the commercialization of the payment processing platform for Australia's public and private health claims market. He also led the global market commercialization of the imaging technology platform at Resonance Health (ASX:RHT). Mr Smith holds a number of public and private company directorships and is a venture investor in a number of technology enterprises.

Mr Philip John Carulli Non-Executive Director Aug 2018 Director Bio icon

Mr Philip John Carulli

Non-Executive Director

Mr Carulli is managing director of Optima Financial Group Pty Ltd where he provides financial, taxation and corporate advisory services to a range of businesses. Over the past 23 years Mr Carulli has owned, managed and consulted to companies in professional services, construction, technology, medical, and industrial sectors to name a few. Mr Carulli also has experience in working with technology and R&D businesses.

Mr Michael Dean Vegar Co-Founder,Chief Executive Officer,Managing Director Nov 2015 Director Bio icon

Mr Michael Dean Vegar

Co-Founder,Chief Executive Officer,Managing Director

Mr Vegar has experience in the sporting industry across a variety of roles with more than 13 years of domain knowledge. Before co-founding HitIQ, Mike operated a sport science consultancy firm advising various professional and semi-professional sporting programs from 2008 - 2017, including working in the High-Performance Unit at the Australian Institute of Sport with the Australian Men's Hockey program. In that role, Mr Vegar was responsible for managing the injury rehabilitation and physical preparation programming. In 2012, Mr Vegar also co-founded Game Guardian, a Australian manufacturer of mouth guards and sports protection goods, which he exited in 2020.

Mr Peter Patrick Torre Company Secretary N/A

Director Transactions

HIQ directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
02/08/21 Philip Carulli Buy +125,000 $0.16 $20,000 On-market trade

Director Interests

The current holdings of HIQ directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Philip Carulli 02/08/2021 N/A 2,228,334 700,000 N/A
Aidan Clarke 17/04/2021 125,000 250,000 N/A N/A
Otto Buttula 28/01/2021 N/A 4,533,334 N/A N/A
Glenn Smith 06/01/2020 112,500 100,000 N/A N/A
Michael Vegar 27/11/2015 375,000 6,729,166 6,000,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Jun 8, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Michael Dean Vegar (M Vegar Investment A/C) 6,666,666 5.03%
Mach Industries Pty Ltd (Lang Family A/C) 5,600,000 4.23%
Webinvest Pty Ltd (Olsb Unit A/C) 3,166,667 2.39%
VT Investments Pty Ltd(A & M Taddei Family A/C) 3,106,106 2.35%
Madj Innovations Pty Ltd 3,000,000 2.27%
Jaskan Investments Pty Ltd (Lynia Super Fund A/C) 2,861,939 2.16%
Namarong Investments Pty Ltd (Hansen Investment A/C) 2,311,187 1.75%
Radell Pty Ltd (Mackay Family S/F A/C) 2,083,333 1.57%
Mr Murray Edward Bleach & Mrs Norma Leigh Edwards (The Bleach Super A/C) 2,083,333 1.57%
Prokam Pty Ltd 1,937,500 1.46%
Mr Robert John Wittenoom 1,766,667 1.33%
LDU Pty Ltd(Vesty Super Fund A/C) 1,628,000 1.23%
Botsis Holdings Pty Ltd 1,506,250 1.14%
Tipela Investments Pty Ltd (The Carulli Investment A/C) 1,460,000 1.10%
Newfound Investments Pty Ltd(Newfound Super Fund A/C) 1,366,667 1.03%
Collingwood Football Club Limited 1,333,334 1.01%
Mrs Judith Piggin & Mr Damien Piggin & Mr Glenn Piggin (Piggin Family S/F A/C) 1,279,000 0.97%
Rock The Polo Pty Ltd 1,237,500 0.93%
Dafi Investments Pty Ltd 1,182,000 0.89%
Troca Enterprises Pty Ltd (Coulson Super A/C) 1,166,667 0.88%
Davft Pty Ltd (Davenport Family A/C) 1,125,000 0.85%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 0 0 43 495 263 801

Substantial Shareholders

No Substantial Shareholders for HIQ in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
16-06-21 Michael Vegar 7,104,166 -- 5.36

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
Page Icon
HIQ Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.